CoreCap Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.43M Buy
24,801
+1,038
+4% +$59.6K 0.04% 309
2026
Q1
$1.44M Buy
23,763
+110
+0.5% +$6.41K 0.05% 297
2025
Q4
$1.28M Buy
23,653
+3,344
+16% +$161K 0.04% 327
2025
Q3
$916K Buy
20,309
+2,613
+15% +$122K 0.03% 393
2025
Q2
$819K Sell
17,696
-1,200
-6% -$58.9K 0.03% 390
2025
Q1
$1.15M Buy
18,896
+1,395
+8% +$81.3K 0.05% 304
2024
Q4
$990K Buy
17,501
+3,345
+24% +$187K 0.05% 334
2024
Q3
$732K Buy
+14,156
New +$664K 0.03% 378
2024
Q2
Sell
-9,126
Closed -$495K 1725
2024
Q1
$495K Buy
9,126
+1,517
+20% +$77.3K 0.03% 401
2023
Q4
$390K Buy
7,609
+1,944
+34% +$102K 0.03% 389
2023
Q3
$329K Buy
5,665
+991
+21% +$60.7K 0.02% 398
2023
Q2
$299K Buy
+4,674
New +$313K 0.02% 455
2022
Q4
$1.73M Buy
24,090
+19,061
+379% +$1.44M 0.12% 151
2022
Q3
$358K Sell
5,029
-261
-5% -$18.9K 0.03% 389
2022
Q2
$407K Sell
5,290
-2,275
-30% -$173K 0.03% 358
2022
Q1
$552K Sell
7,565
-223
-3% -$15K 0.04% 317
2021
Q4
$486K Buy
+7,788
New +$457K 0.03% 371

Other funds holding BMY

CoreCap Advisors's BMY Position: Q2 2026 in Review

CoreCap Advisors increased its Bristol-Myers Squibb (BMY) stake by 4.4% in Q2 2026, buying an estimated $59.6K and bringing the position to 24,801 shares worth $1.43M. The position accounts for 0.04% of the portfolio, ranked #309.

CoreCap Advisors first reported a position in BMY in Q4 2021 and has held it in 17 quarters since. The position peaked at $1.73M in Q4 2022. 879 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • CoreCap Advisors held 24,801 shares of Bristol-Myers Squibb worth $1.43M as of Q2 2026.
  • CoreCap Advisors bought 1,038 Bristol-Myers Squibb shares in Q2 2026, an estimated $59.6K.
  • Bristol-Myers Squibb made up 0.04% of CoreCap Advisors's portfolio in Q2 2026, its #309 holding.
  • CoreCap Advisors first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 17 quarters since.
  • CoreCap Advisors's Bristol-Myers Squibb position peaked at $1.73M in Q4 2022.
  • 879 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.